Gordon Broderick
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Gordon Broderick, PhD, is an associate professor at the University of Alberta, as well as part of Dr. Nancy Klimas’ Institute for Neuro Immune Medicine at Nova Southeastern University (NSU). He regularly serves on National Institutes of Health (NIH) study sections for chronic fatigue syndrome research.[1]
Education[edit | edit source]
- Undergarduate - Mechanical Engineering from McGill University
- Masters - Chemical Engineering from McGill University
- Doctorate - Chemical Engineering from the University of Montreal
- Post-doctorate - McGill’s School of Computer Science in cancer genomics
- Research fellowship - Computational Biochemistry at the University of Alberta[2]
International Consensus Criteria[edit | edit source]
Dr Broderick participated in the team that authored the 2011 case definition, International Consensus Criteria (ICC).[3]
Open Letter to The Lancet[edit | edit source]
Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Broderick, along with 41 colleagues in the ME/CFS field, signed the second letter.
- 10 February 2016, An open letter to The Lancet, again - Virology blog[4]
Notable studies in ME/CFS[edit | edit source]
- 2008, Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.[5] (Abstract)
- 2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis[6] (Full Text)
- 2010, Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26[7] - (Full Text)
- 2010, A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome[8]
- 2010, Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia[9] (Full Text)
- 2010, Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome[10] - (Full Text)
- 2011, Myalgic encephalomyelitis: International Consensus Criteria[11]
- 2012, Biomarkers for chronic fatigue.[12] (Full Text)
- 2012, Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue[13] (Full Text)
- 2014, A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome[14] (Full Text)
- 2015, Using gene expression signatures to identify novel treatment strategies in gulf war illness[15] - (Full text)
- 2016, Tracking post-infectious fatigue in clinic using routine Lab tests[16] (Full Text)
- 2016, Illness progression in chronic fatigue syndrome: a shifting immune baseline[17] (Full Text)
- 2017, Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[18] (Full Text)
- 2018, High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology[19] (Abstract)
- 2019, Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome[20] (Abstract)
- 2019, From biomarkers to targeted treatment: The myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and gulf war illness (GWI) story[21] (Abstract)
- 2019, Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary[22] (Abstract)
- 2019, Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of Gene-expression Modules[23] - (Abstract)
Talks and interviews[edit | edit source]
- 2009, Gordon Broderick on ME/CFS: the PANDORA Interview (Phoenix Rising)
- 2014, Models Suggesting Chronic Fatigue Syndrome Is “Amenable to Intervention” Provide Hope: Dr. Broderick Talks (Health Rising)
- 2015, Modelling Exercise Dynamics to Restore Immune Signaling in ME/CFS (Institute for Neuro Immune Medicine)
Online presence[edit | edit source]
- PubMed
- ResearchGate
- Profile page for the Institute for Neuro Immune Medicine]
- Gordon Broderick, Ph.D. - University of Alberta
See also[edit | edit source]
Learn more[edit | edit source]
References[edit | edit source]
- ↑ Gordon Broderick, Ph.D. - University of Alberta
- ↑ "NOVA bio".
- ↑ Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A.C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
- ↑ Tuller, Date (February 10, 2016). "An open letter to The Lancet, again". Virology blog. Retrieved August 14, 2018.
- ↑ Aspler, AL; Bolshin, C; Vernon, SD; Broderick, G (2008), "Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood", Behavioral and Brain Functions, 4 (44), doi:10.1186/1744-9081-4-44
- ↑ Fuite, Jim; Vernon, Suzanne; Broderick, Gordon (2008), "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis.", Genomics, 92 (6): 393-9, doi:10.1016/j.ygeno.2008.08.008
- ↑ Fletcher, Mary A.; Zeng, Xiao R.; Maher, Kevin; Levis, Silvina; Hurwitz, Barry; Antoni, Michael; Broderick, Gordon; Klimas, Nancy G. (May 25, 2010). Unutmaz, Derya (ed.). "Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV/CD26". PLoS ONE. 5 (5): e10817. doi:10.1371/journal.pone.0010817. ISSN 1932-6203. PMC 2876037. PMID 20520837.
- ↑ Broderick, Gordon; Fuite, Jim; Kreitz, Andrea; Vernon, Suzanne; Klimas, Nancy; Fletcher, Mary Ann (2010), "A Formal Analysis of Cytokine Networks in Chronic Fatigue Syndrome", Brain, Behavior, and Immunity, 24 (7): 1209–1217, doi:10.1016/j.bbi.2010.04.012
- ↑ Nakamura, T; Schwander, S; Donnelly, R; Ortega, F; Togo, F; Broderick, G; Yamamoto, Y; Cherniack, NS; Rapoport, D; Natelson, BH (2010), "Cytokines across the Night in Chronic Fatigue Syndrome with and without Fibromyalgia", Clinical and Vaccine Immunology, 17 (4): 582–587, doi:10.1128/CVI.00379-09
- ↑ Fletcher, Mary Ann; Rosenthal, Martin; Antoni, Michael; Ironson, Gail; Zeng, Xiao R; Barnes, Zachary; Harvey, Jeanna M; Hurwitz, Barry; Levis, Silvina; Broderick, Gordon; Klimas, Nancy G (2010), "Plasma neuropeptide Y: a biomarker for symptom severity in chronic fatigue syndrome", Behavioral and Brain Functions, 6 (76), doi:10.1186/1744-9081-6-76
- ↑ Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A.C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
- ↑ Klimas, NG; Broderick, G; Fletcher, MA (2012), "Biomarkers for chronic fatigue.", Brain Behav Immun, 26 (8): 1202-10, doi:10.1016/j.bbi.2012.06.006, PMID 22732129
- ↑ Broderick, Gordon; Katz, Ben Z; Fernandes, Henrique; Fletcher, Mary Ann; Klimas, Nancy; Smith, Frederick A; O'Gorman, Maurice RG; Vernon, Suzanne D; Taylor, Renee (2012), "Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue", Journal of Translational Medicine, 10 (191), doi:10.1186/1479-5876-10-191
- ↑ Craddock, Travis J.A.; Fritsch, Paul; Rice, Jr, Mark A.; del Rosario, Ryan M.; Miller, Diane B.; Fletcher, Mary Ann; Klimas, Nancy G.; Broderick, Gordon (2014), "A Role for Homeostatic Drive in the Perpetuation of Complex Chronic Illness: Gulf War Illness and Chronic Fatigue Syndrome", PLOS One, 9 (1): e84839, doi:10.1371/journal.pone.0084839
- ↑ Craddock, Travis J.A.; Harvey, Jeanna M.; Nathanson, Lubov; Barnes, Zachary M.; Klimas, Nancy G.; Fletcher, Mary Ann; Broderick, Gordon (July 9, 2015). "Using gene expression signatures to identify novel treatment strategies in gulf war illness". BMC Medical Genomics. 8. doi:10.1186/s12920-015-0111-3. ISSN 1755-8794. PMC 4495687. PMID 26156520.
- ↑ Harvey, Jeanna M.; Broderick, Gordon; Bowie, Alanna; Barnes, Zachary M.; Katz, Ben Z.; O'Gorman, Maurice R.G.; Vernon, SuzanneD.; Fletcher, Mary Ann; Klimas, Nancy G. (April 26, 2016). "Tracking post-infectious fatigue in clinic using routine Lab tests". BMC Pediatrics. 15: 54. doi:10.1186/s12887-016-0596-8. ISSN 1471-2431. PMC 4847210. PMID 27118537.
- ↑ Russell, Lindsey; Broderick, Gordon; Taylor, Renee; Fernandes, Henrique; Harvey, Jeanna; Barnes, Zachary; Smylie, AnneLiese; Collado, Fanny; Balbin, Elizabeth G.; Katz, Ben Z.; Klimas, Nancy; Fletcher, Mary Ann (2016), "Illness progression in chronic fatigue syndrome: a shifting immune baseline", BMC Immunology, 17 (3), doi:10.1186/s12865-016-0142-3
- ↑ Cook, Dane B.; Light, Alan R.; Light, Kathleen C.; Broderick, Gordon; Shields, Morgan R.; Dougherty, Ryan J.; Meyer, JacobD.; VanRiper, Stephanie; Stegner, Aaron J.; Ellingson, LauraD.; Vernon, SuzanneD. (2017), "Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Brain, Behavior, and Immunity, doi:10.1016/j.bbi.2017.02.009
- ↑ Sedghamiz, Hooman; Morris, Matthew; Craddock, Travis J.A.; Whitley, Darrell; Broderick, Gordon (July 17, 2018). "High-fidelity discrete modeling of the HPA axis: a study of regulatory plasticity in biology". BMC Systems Biology. 12 (76). doi:10.1186/s12918-018-0599-1.
- ↑ Morris, Matthew C.; Cooney, Katherine E.; Sedghamiz, Hooman; Abreu, Maria; Collado, Fanny; Balbin, Elizabeth G.; Craddock, Travis J.A.; Klimas, Nancy G.; Broderick, Gordon; Fletcher, Mary Ann (March 2019). "Leveraging Prior Knowledge of Endocrine Immune Regulation in the Therapeutically Relevant Phenotyping of Women With Chronic Fatigue Syndrome". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.03.002.
- ↑ Klimas, N.G.; Fletcher, M.A.; Abreu, M.M.; Aenlle, K.; Craddock, T.; Broderick, G. (February 2019). "From biomarkers to targeted treatment: The myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and gulf war illness (GWI) story". Brain, Behavior, and Immunity. 76: e40. doi:10.1016/j.bbi.2018.11.301.
- ↑ Richman, Spencer; Morris, Matthew C.; Broderick, Gordon; Craddock, Travis J.A.; Klimas, Nancy G.; Fletcher, Mary Ann (March 2019). "Pharmaceutical Interventions in Chronic Fatigue Syndrome: A Literature-based Commentary". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.02.011.
- ↑ Jeffrey, Mary G.; Nathanson, Lubov; Aenlle, Kristina; Barnes, Zachary M.; Baig, Mirza; Broderick, Gordon; Klimas, Nancy G.; Fletcher, Mary Ann; Craddock, Travis J.A. (March 2019). "Treatment Avenues in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Split-gender Pharmacogenomic Study of Gene-expression Modules". Clinical Therapeutics. doi:10.1016/j.clinthera.2019.01.011.